FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2022/05/042431 [Registered on: 10/05/2022] Trial Registered Prospectively
Last Modified On: 09/05/2022
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Physiotherapy (Not Including YOGA) 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Impact of Non-Invasive Neuromodulation and Genital Nerve Stimulation on bladder function in Spinal Cord Injury 
Scientific Title of Study   Integrated Effect of Non-Invasive Neuromodulation and Genital Nerve Stimulation on bladder function in Traumatic Spinal Cord Injury Patients  
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Priyanka Dangi 
Designation  PhD Scholar 
Affiliation  Punjabi University 
Address  Department of Physiotherapy

Patiala
PUNJAB
147001
India 
Phone  7610252020  
Fax    
Email  priyankadangi517@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Narkeesh Arumugam 
Designation  Professor  
Affiliation  Punjabi University 
Address  Department of Physiotherapy

Patiala
PUNJAB
147001
India 
Phone  9417802662  
Fax    
Email  narkeesh@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Narkeesh Arumugam 
Designation  Professor  
Affiliation  Punjabi University 
Address  Department of Physiotherapy


PUNJAB
147001
India 
Phone  9417802662  
Fax    
Email  narkeesh@gmail.com  
 
Source of Monetary or Material Support  
Punjabi University, Patiala, Punjab (147001) 
 
Primary Sponsor  
Name  Punjabi University  
Address  Department of Physiotherapy Punjabi University Patiala Punjab 
Type of Sponsor  Research institution 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Narkeesh Arumugam  Punjabi university  outpatient department department of physiotherapy
Patiala
PUNJAB 
9417802662

narkeesh@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL ETHICAL COMMITTEE  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: G968||Other specified disorders of central nervous system,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Non-Invasive neruomodulation (rTMS)  rTMS (biphasic single pulses (duration 250 µs) continuous, magnetic stimulation each stimulation period of total 13 minutes (a total of 12 minutes of stimulation plus 1 minute of break) at 1Hz) + Genital nerve stimulation (continuous, rectangular Biphasic current, charge-balanced, 200 microsecond pulse width square waves, cathodic leading pulses are delivered at 20 Hz) + conventional physiotherapy 5 session for 4 weeks  
Comparator Agent  sham non-invasive neuromodulation (rTMS)  shamm rTMS + genital nerve stimulation (continuous, rectangular Biphasic current, charge-balanced, 200 microsecond pulse width square waves, cathodic leading pulses are delivered at 20 Hz) + conventional physiotherapy 5 session for 4 weeks 
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  50.00 Year(s)
Gender  Both 
Details  1. Has traumatic Spinal Cord Injury with spastic overactive bladder.
2. The duration of injury will be more than 6 months.
3. Individuals, who are willing to participate, give consent form and able to follow
commands.
4. Both Males and Females.
5. Individuals of the Age Group (20-50 Years). 
 
ExclusionCriteria 
Details  1. Individual with non-traumatic spinal cord injury with hyporeflexia or areflexia
bladder.
2. Individual with coexisting cauda equina with flaccid bladder.
3. Any of Gastro-intestinal dysfunction or kidney dysfunction.
4. Individual with any brain injury, degenerative disease, stroke.
5. Individuals with metal implants close to rTMS which are contraindicated.
6. Individuals developed Psychosomatic Illness/ Disease.
7. Non-Cooperative Individuals.
8. Any infected wound, pressure sore (Grade 2 or above).
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
Urodynamics- uroflowmetry, pressure flow study, urethral
pressure profile, cystometry, post void residual volume
Electromyography- latency, amplitude
 
4 weeks
 
 
Secondary Outcome  
Outcome  TimePoints 
Spinal Cord Independence Measure Scale Spinal Cord
Injury- III (SCIM-III)
American Spinal Injury Association (ASIA) Impairment
Scores (AIS)
Incontinence dairy  
4 weeks 
 
Target Sample Size   Total Sample Size="50"
Sample Size from India="50" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 1/ Phase 2 
Date of First Enrollment (India)   12/05/2022 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   Protocol Publication Case study publication Case series publication Systematic Review Publication Complete study Publication  
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Need of the Study

            Bladder incontinence has a huge impact on individual’s quality of life with significant change in behaviour both socially and psychologically. There is high rate of morbidity and mortality rate due to deterioration in lower urinary tract. Maintaining good hygiene of the bladder is the biggest problem associated with the management of bladder dysfunction following SCI. The mismanaged bladder led to overdistended bladder, larger volume of urine output, resulting in the leakage of urine which is harmful to the bladder and the kidneys. SCI survivors depend on others for their basic Activity of daily living (ADL), which create worse impact on their personality in every domain of life.

Bladder rehabilitation is overlooked in developing countries due to a circular sequence of events like fear, embarrassment in discussing the problem. A loss of self-esteem and confidence, personal and social isolation, psychologic symptoms such as depression, apathy and anger contribute for not giving preference to bladder rehabilitation. 

In the present arena, treatment scenario has been modified significantly for bladder rehabilitation and also bladder rehabilitation is given foremost importance in neuro-rehabilitation set-ups. The conventional methods of treatment including medication, invasive stimulation, nerve blocks work symptomatically but they are not efficient in restoring the bladder function permanently. Various non-invasive techniques are used in clinical set ups to improve bladder function, but they are less effective and not for prolonged use. Various Stimulation technique are difficult to tolerate for every individual due to high intensity current application (Gad et al.,2015), not cost effective, immediate results are not obtained and not feasible for every clinical set up.

Hence, there is strong need to adopt the methods to restore the bladder function which are endurable, easy to administer, non-invasive and will be cost effective. Non–invasive Neuromodulation is a real and growing healthcare application driven by advances in neuroscience capabilities.  Restoration of bladder function via non-invasive neuromodulation is a topic of current interest of research.

            Hence, the present study attempts to determine the integrated effect of non- invasive neuromodulation and genital nerve stimulation on bladder function in traumatic SCI patients.

Aim of the Study

To determine the integrated effect of Non-Invasive Neuromodulation through repetitive Trans-Magnetic Stimulation (rTMS) with Genital Nerve Stimulation in traumatic Spinal Cord Injury patients with special reference to Urinary Bladder Function.

Objectives of the Study

To determine the effect of Genital Nerve Stimulation alone and in combination with non-invasive neuromodulation through Repetitive Trans-Magnetic stimulation, rTMS on urinary bladder function in Individuals following traumatic SCI.

1.     1. On sensory-motor improvement through ASIA impairment score. 

2.     2. On the Genito-anal reflex and to monitor pelvic floor activity via EMG-MEP (Electromyography).

3.     3. On bladder function i.e. retention, voiding and bladder contraction through Urodynamics: uroflowmetry, pressure flow study, urethral pressure profile, cystometry, post void residual volume

4.     4. On functional activity through Spinal Cord Independence Measure Scale-III (SCIM-III).

Methodology

Nature of the Study

The present study will be a prospective randomized controlled clinical trial.  Participants will be selected based on the sample selection criteria and will be randomly allocated into two groups i.e. (Experimental Group A), (Experimental Group B).

Consent and Ethical Considerations

Ethical approval for the present study has been taken from the Institutional Ethical Committee, Punjabi University, and Patiala. Written consent will be taken from all the participants, willing to participate, prior to the commencement of the study.

Study Population

SCI survivors with the age Group (20-50 years) will constitute the Population of the study. The participants will be selected from Various Physiotherapy/rehabilitation Centres/Hospitals in and around Punjab. 

 

Sampling Method

The computer-generated random sampling method will be used to allocate the participants in control and experimental group. The randomisation schedule for all participants will established prior to recruitment by the researcher using a computer-generated random list (https://www.graphpad.com/quickcalcs/randomize2/).

Study settings

·       OPD of Department of physiotherapy, Punjabi university, Patiala, Punjab. 

·       Neuroots Clinic, Patiala. Punjab.

·       Indian Spinal Injury Centre, Vasant Kunj New Delhi.

Sample Size

            G Power software was used for sample size calculation (Erdfelder, 2009; Erdfelder, 2007). The calculated sample size for the study is 40. Given reasonable attrition rate of 5%, the final sample size calculation, was done using formula.

N 1 = Total Sample size, N=Calculated Sample size, q= Proportion of attrition

N 1 (The final sample size calculated to be 50, with (n=25) in each group.

Protocol

Participants having SCI will be selected as per selection criteria

Written consent will be obtained from the participants prior to the commencement of the study

Baseline Assessment will be done for the outcome measures of the study ASIA score, Electromyography, urodynamics, SCIM-III

Participants will be randomly allocated into 2 groups (N=50)

Group A (Experimental Group) (n = 25) rTMS+Genital Nerve Stimulation + Conventional Physiotherapy 5 session weekly, for 4 weeks  

Group B (Control Group) (n = 25) Sham rTMS + Genital Nerve Stimulation + Conventional Physiotherapy 5 session weekly, for 4 weeks

Post Intervention assessment will done at Day 15 and Day 30 for outcome measures of the study ASIA Score, EMG, urodynamics, SCIM-III.

Data will be collected

Statistical analysis of the data will be done using SPSS Version 16.0




 
Close